Skip to main content
Clinical Trials/NCT05725655
NCT05725655Active, not recruitingNot Applicable

Hot Water Immersion in Rehabilitation After Myocardial Infarction (HOT-MI) - a Randomized Controlled Study

Region Örebro County2 sites in 1 country30 target enrollmentStarted: October 26, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
30
Locations
2
Primary Endpoint
Concentrations of interleukin 6 (IL-6) in blood

Study Overview

Brief Summary

Myocardial infarction (MI) is a leading cause of death in developed countries, including Sweden. Standard treatment for patients after MI includes exercise-based cardiac rehabilitation which contributes to improved cardiovascular function and reduces the risk of hospital readmissions, new cardiovascular events and mortality. Thermotherapy may also have beneficial effects on cardiovascular disease by a reduction in inflammatory status and improved metabolism and vascular function. Given the well-documented effects of exercise training on cardiac rehabilitation and recent evidence that thermotherapy may improve cardiovascular function, we wish to investigate the effect of exercise combined with hot water immersion (HWI) in cardiac rehabilitation post-MI.

This is a single-centre, randomized controlled clinical trial in patients with recent MI. Our aim is to investigate whether exercise training combined with HWI improves inflammatory and metabolic status, cardiovascular function as well as psychological well-being, compared with exercise training alone. Patients will be randomized 1:1 to an 8 week intervention with exercise training 2 times per week followed by 15 minutes of hot water immersion, or to a control group with exercise training alone. The primary endpoint is changes in the inflammatory marker interleukin (IL-) 6 between groups at 8 weeks. Secondary endpoints include other biomarkers of inflammation, metabolism, effects on cardiovascular function and psychological benefits.

Secondary prevention after MI has improved during the last decades but readmissions and death following acute MI remain large health challenges. If HWI in addition to standard cardiac rehabilitation can lower inflammation more than standard therapy alone, and improve metabolic, cardiovascular and psychological status, it could be a cost-effective and safe complementary strategy for secondary prevention after MI, particularly for those with limited exercise capability.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with a diagnosis of ST-elevation myocardial infarction (STEMI) or non-STEMI
  • Concomitant participation in standard care exercise-based cardiac rehabilitation
  • Male or female patients ≥ 18 years
  • Written informed consent

Exclusion Criteria

  • Regularly performing hot water immersion, sauna or other types of thermotherapy
  • Not willing to perform hot water immersion regularly
  • Febrile illness or acute, ongoing infection
  • <18 years of age
  • Inability to provide informed consent

Arms & Interventions

Hot water immersion

Experimental

Patients allocated to hot water immersion will enter a bath and submerge down to the neck in warm water (40 degrees celsius) for 20 min.

Intervention: Thermotherapy (Other)

Control

No Intervention

Patients allocated to control group will sit down for a 20 min rest.

Outcomes

Primary Outcomes

Concentrations of interleukin 6 (IL-6) in blood

Time Frame: 8 weeks (aiming at 16 bath (or control) sessions during the intervention period

Change in IL-6 between groups after 8 weeks of intervention (aiming at 16 bath (or control) sessions during the intervention period)

Secondary Outcomes

  • Concentrations of biomarkers of metabolism in blood(8 weeks)
  • Change in sympathetic/parasympathetic activity(8 weeks)
  • Concentrations of other biomarkers of inflammation in blood(8 weeks)
  • Change in percent in endothelial flow-mediated dilatation (FMD)(8 weeks)
  • Change in diastolic and systolic blood pressure (mm(Hg)(8 weeks)
  • Change in score of participants´ subjectively reported psychological well-being(8 weeks)

Investigators

Sponsor
Region Örebro County
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials